Back to Prevention

Can the UK Actually End New HIV Transmissions?

Can the UK Actually End New HIV Transmissions?
Bareback Guide 19 March 2026

England has adopted a target of ending new HIV transmissions by 2030, with similar ambitions elsewhere in the UK. It is a genuinely plausible goal rather than rhetoric, but the transmissions that remain are the hardest ones to prevent, and progress has slowed in some groups while continuing in others.

What has already been achieved?

New diagnoses in gay and bisexual men have fallen substantially from their peak, driven by expanded testing, rapid treatment starts and the routine availability of PrEP. The UK has reached high levels on the international benchmarks measuring the proportion of people living with HIV who are diagnosed, in care and virally suppressed. Very few babies are born with HIV in the UK, because antenatal testing and treatment are near universal.

What does ending transmissions actually mean?

Not eradicating HIV, and not curing anyone. It means no new infections acquired within the country. People living with HIV would continue to live with it and continue on treatment; the aim is that the chain of onward transmission stops.

What stands in the way?

Undiagnosed infection, principally. Treatment as prevention only works on infections that have been found, and the people who remain undiagnosed are by definition those the existing system has not reached. Late diagnosis remains common, particularly among heterosexual men and older adults, both of whom test far less often than gay and bisexual men.

Where is progress uneven?

Diagnoses among heterosexual men and women have not fallen in the same way, and in some recent periods have risen. PrEP uptake outside gay and bisexual men remains low, partly because awareness is low and partly because services are configured around the group that has used it most. People facing barriers of language, immigration status, housing or stigma are underserved throughout.

What is being tried?

Opt-out blood-borne virus testing in emergency departments in higher-prevalence areas, which finds people who would never attend a sexual health clinic and has identified substantial numbers of undiagnosed infections. Expanded postal testing. Efforts to widen PrEP access beyond sexual health clinics. Better implementation of testing on indicator conditions in general practice.

What could go wrong?

Funding is the obvious risk, since sexual health services in England are commissioned by local authorities whose budgets have been under sustained pressure. Waiting times in some areas already obstruct access. Complacency is another: falling diagnoses reduce the political urgency that produced the investment in the first place.

Does individual behaviour matter?

Yes, and in a fairly direct way. Testing every three months, taking PrEP if you are eligible, staying on treatment if you are living with HIV, and taking up partner notification when offered are each small contributions to the same total. This is one of the few areas where the gap between personal action and population outcome is genuinely short.

What about HIV acquired abroad?

The target concerns transmissions occurring within the UK. A substantial proportion of new diagnoses here are in people who acquired HIV elsewhere, and those will continue regardless of domestic progress. This is not a loophole; it reflects that the thing being measured is the domestic transmission chain, and it is why diagnosis and treatment for everyone regardless of immigration status matters as much as prevention.

Is the target achievable?

Possibly, and the honest answer is that it depends less on new science than on reaching people the system currently misses. Every tool needed already exists and is free at the point of use. The remaining question is distribution rather than discovery.

What would it take from services?

Sustained funding for sexual health, expanded routine testing outside sexual health settings, PrEP available beyond specialist clinics, and outreach to groups the current model does not reach. None of that requires new science, which is unusual for a public health target.

What about people already living with HIV?

Ending transmissions does not mean they disappear from the picture. An ageing population living with HIV needs care for cardiovascular health, bone density, cognition and everything else, alongside continued attention to stigma. A target focused only on new cases risks underinvesting in the people already here.